Updated Results of Cartitude-2: Ciltacabtagene Autoleucel (cilta-cel), a B-Cell Maturation Antigen (BCMA)–Directed Chimeric Antigen Receptor T Cell (CAR-T) Therapy, in Lenalidomide-Refractory Patients with Progressive Multiple Myeloma (MM) after 1–3 Prior Lines of Therapy

Details

Language :

English

ISSN :

26666375 and 26666367

Volume :

28

Issue :

3, Number 3 Supplement 1

Database :

Supplemental Index

Journal :

Transplantation and Cellular Therapy

Publication Type :

Periodical

Accession number :

ejs59182748

Full Text :

https://doi.org/10.1016/S2666-6367(22)00234-2